Literature DB >> 6815666

GABAergic influences on defensive fighting in rats.

R J Rodgers, A Depaulis.   

Abstract

The involvement of GABAergic mechanisms in shock-induced defensive fighting in rats was investigated in a series of three experiments. In Experiment 1, sodium n-dipropylacetate (100-200 mg/kg) failed to produce significant behavioural change whilst gamma-vinyl-GABA (100-200 mg/kg) induced a selective and dose-dependent reduction in fighting. In Experiment 2, although inconsistent behavioural effects were obtained with (+)-bicuculline (0.25-4 mg/kg), a biphasic influence on defensive fighting was observed with picrotoxin (0.125-2 mg/kg). The inhibitory effect on fighting, induced by the highest dose of picrotoxin, was related to motor impairment. In Experiment 3, muscimol reduced fighting at doses above 0.25 mg/kg with motor disruption evident only at the highest dose used (1 mg/kg). A dose-dependent inhibition of defensive fighting was observed with 1-baclofen (0.15-1.2 mg/kg) which, at the highest dose tested, also impaired motor coordination. None of the compounds tested significantly altered shock thresholds. Results are discussed in relation to the hypothesized inhibitory role of GABA in the mediation of aggressive behaviours.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815666     DOI: 10.1016/0091-3057(82)90303-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  Increased GABAA-dependent chloride uptake in mice selectively bred for low aggressive behavior.

Authors:  E M Weerts; L G Miller; K E Hood; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Growth hormone responses to GABAB receptor challenge with baclofen and impulsivity in healthy control and personality disorder subjects.

Authors:  Royce Lee; Berdine Chong; Emil Coccaro
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

3.  Behavioral characterization of escalated aggression induced by GABA(B) receptor activation in the dorsal raphe nucleus.

Authors:  Aki Takahashi; Arielle N Schilit; Jisoo Kim; Joseph F Debold; Tsuyoshi Koide; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2012-03-07       Impact factor: 4.530

Review 4.  Neurogenetics of aggressive behavior: studies in rodents.

Authors:  Aki Takahashi; Klaus A Miczek
Journal:  Curr Top Behav Neurosci       Date:  2014

5.  Gabaergic modulation of mouse-killing in the rat.

Authors:  A Depaulis; M Vergnes
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 6.  Alcohol and violence: neuropeptidergic modulation of monoamine systems.

Authors:  Klaus A Miczek; Joseph F DeBold; Lara S Hwa; Emily L Newman; Rosa M M de Almeida
Journal:  Ann N Y Acad Sci       Date:  2015-08-18       Impact factor: 5.691

7.  Benzodiazepines and heightened aggressive behavior in rats: reduction by GABA(A)/alpha(1) receptor antagonists.

Authors:  Shannon L Gourley; Joseph F Debold; Wenyuan Yin; James Cook; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2004-08-17       Impact factor: 4.530

8.  Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior.

Authors:  Scott D Lane; Joshua L Gowin; Charles E Green; Joel L Steinberg; F Gerard Moeller; Don R Cherek
Journal:  Pharmacol Biochem Behav       Date:  2009-04       Impact factor: 3.533

9.  Acute effects of gabapentin on laboratory measures of aggressive and escape responses of adult parolees with and without a history of conduct disorder.

Authors:  Don R Cherek; Oleg V Tcheremissine; Scott D Lane; Cynthia J Pietras
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

10.  GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice.

Authors:  Joyce Besheer; Veronique Lepoutre; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.